World Athletics president Sebastian Coe says the track and field's governing body has approved the introduction of cheek ...
Joining us today are Oncocyte President and CEO, Josh Riggs; Chief Science Officer, Ekke Schutz; and CFO, Andrea James. We ...
Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...
Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...
The global coronavirus immunoassay market continues to witness steady growth, reaching USD 3.7 billion in 2021 and is projected to exceed USD 6.9 billion by 2032, expanding at a CAGR of 5.5% during ...
The company also reported that its fourth quarter revenues dropped 7 percent from a year ago, while full-year 2024 revenues declined 3 percent.
Pharmaceutical company sponsorship of diagnostic testing remains an area with a gaping divide between the views of regulators and industry, ...
According to Research by SNS Insider, Point-of-Care Diagnostics Market Growth is Fueled by Technological Advancements and Rising Prevalence of Chronic DiseasesPune, March 21, 2025 (GLOBE NEWSWIRE) -- ...